Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)

Stopped The certification of cell-based treatment in the settings need to be updated.

Conditions

• Bronchopulmonary Dysplasia

Interventions

• DRUG: Human Umbilical Cord-derived Mesenchymal stem cell
• DRUG: placebo

Sponsor

Children's Hospital of Fudan University